title: Proarrhythmic potential of amiodarone: an underestimated risk?
authors.forename: Alfonso
authors.initials: A
authors.lastname: Jurado Román
authors.forename: Belén
authors.initials: B
authors.lastname: Rubio Alonso
authors.forename: Roberto
authors.initials: R
authors.lastname: Martín Asenjo
authors.forename: Rafael
authors.initials: R
authors.lastname: Salguero Bodes
authors.forename: María
authors.initials: M
authors.lastname: López Gil
authors.forename: Fernando
authors.initials: F
authors.lastname: Arribas Ynsaurriaga
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000503:physiopathology; D002311:Cardiomyopathy, Dilated / Q000150:complications; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007262:Infusions, Intravenous; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications; D012306:Risk; D017180:Tachycardia, Ventricular / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000139:chemically induced
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone